A recent report in The Times of India reveals that Roche may have profited immensely from risdiplam, a drug for spinal muscular atrophy (SMA), potentia...
Zymo Research is a top competitor of MACHEREY-NAGEL. Zymo Research was founded in 1994, and is headquartered in Irvine, California. Like MACHEREY-NAGEL, Zymo Research also competes in the Biotechnology field. Zymo Research generates $18.5M less revenue vs. MACHEREY-NAGEL.